Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis

Trial Objective

The purpose of this study is to learn more about how specific proteins (histones) control your genes and control the inflammation in your lungs which subdquently affect how your sarcoidosis acts. By better understanding how these proteins affect inflammation we can better target them with new treatments. 

If you agree to take part in this study, it will require up to 3 visits.

  • Blood draw

  • Bronchoscopy


And unless done for clinical purposes:
  • Spirometry
  • Chest X-ray

Enrollment

This trial is active and currently recruiting.

How to Participate

For more information, call 303.398.1699 or complete the form below.

Who Can Participate

  • Adults 18 years of age and older who have biopsy-proven sarcoidosis

  • Not currently on immunosupressive therapy

  • Non-smoker


Age

18-85


Gender

Any Gender

Trial Location

National Jewish Main Campus, Denver, CO

Compensation

Provided

Trial Sponsors

NIH


Estimated Time Commitment

Up to 2 visits (1-4 hours long)

Principal Investigators

  • image description
    Nabeel Hamzeh, MD, FCCP

Request More Information

*
*
*
*